Prion Diseases
A group of genetic, infectious, or sporadic degenerative human and animal nervous system disorders associated with abnormal PRIONS. These diseases are characterized by conversion of the normal prion protein to an abnormal configuration via a post-translational process. In humans, these conditions generally feature DEMENTIA; ATAXIA; and a fatal outcome. Pathologic features include a spongiform encephalopathy without evidence of inflammation. The older literature occasionally refers to these as unconventional SLOW VIRUS DISEASES. (From Proc Natl Acad Sci USA 1998 Nov 10;95(23):13363-83)
Subtype terms (7)
More specific conditions that are subtypes of Prion Diseases in the MeSH hierarchy.
- Creutzfeldt-Jakob Syndrome
1 drug experimental
- Encephalopathy, Bovine Spongiform
- Gerstmann-Straussler-Scheinker Disease
- Insomnia, Fatal Familial
1 drug approved
- Kuru
- Scrapie
- Wasting Disease, Chronic
14 drugs (3 approved, 11 experimental)
Drugs by status
Phase 2 trials (1)
Other trials (1)
Organizations
Organization Involved with Other Experimental Indications (1)